<DOC>
	<DOC>NCT01303536</DOC>
	<brief_summary>The aim of this study is to evaluate whether ondansetron augmentation to SSRI will improve and ondansetron discontinuation will result in worsening of obsessive compulsive symptoms among obsessive compulsive disorder resistant patients.</brief_summary>
	<brief_title>Ondansetron Augmentation in Treatment-resistant OCD</brief_title>
	<detailed_description />
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>a diagnosis of OCD established by clinical interview with a licensed psychiatrist; a score of ≥ 24 at the Yale Brown Obsessive Compulsive Scale a Clinical Global Inventory score ≥ 4, after over 12 weeks of treatment with an adequate trial of an selective serotonin reuptake inhibitor at a moderate to high dose diagnoses of schizophrenia, schizoaffective disorder, organic mental disorder, bipolar disorder, current substance dependence or abuse, and current major depressive episode preceding the onset of obsessive compulsive disorder undergoing concomitant behavior therapy or having significant cardiovascular, hepatic, renal or pulmonary diseases</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>